At the moment, pancreatic cancer is among the deadliest gastrointestinal diseases, and
pancreatic cancer growth is a complex biological process that is based on different kinds of …

Several studies were carried out to explore the prognostic role of neutrophil-to-lymphocyte
ratio (NLR) in pancreatic cancer, however, with contradictory results. The objectives of this …

Simple Summary Pancreatic cancer is the fourth leading cause of cancer death in the United
States and over 90% of the patients suffer from pancreatic ductal adenocarcinoma (PDAC) …

Variations in the reporting of potentially confounding variables in studies investigating
systemic treatments for unresectable pancreatic cancer pose challenges in drawing …

Pancreatic ductal adenocarcinoma (PDAC) is among the dangerous human cancers, is the
10th highly prevalent cancer, and the fourth sole cause of cancer-related mortality in the …

Pancreatic ductal adenocarcinoma (PDAC) is an extremely lethal tumor with increasing
incidence, presenting numerous clinical challenges. The histopathological examination of …

Pancreatic Ductal Adenocarcinoma (PDAC) constitutes a leading cause of cancer death
globally. Its mortality remains unaltered despite the considerable scientific progress made in …

Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with an overall 5-year
survival rate of less than 10%. Between 20 and 30% of PDAC cases are resectable at …

Pancreatic cancer is one of the deadliest tumours worldwide, and its poor prognosis is due
to an inability to detect the disease at the early stages, thereby creating an urgent need to …

Simple Summary Based on the four molecular subtypes of pancreatic cancer described by
Bailey et al. 2016, in the present article we match the molecular, histology and …